Shree Ganesh Remedies Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002863, "name": "Shree Ganesh Rem", "stock_name": "Shree Ganesh Rem", "full_name": "Shree Ganesh Remedies Ltd", "name_url": "stocks-analysis/shree-ganesh-rem", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "419.20", "chg": 16.95, "chgp": "4.21%", "dir": 1, "prev_price": "402.25", "mcapval": "526.00 Cr", "mcap": "Micro Cap", "scripcode": 540737, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE414Y01015", "curr_date": "Jan 29", "curr_time": "", "bse_nse_vol": "3.02 k", "exc_status": "Active", "traded_date": "Jan 29, 2026", "traded_date_str": "2026 01 29", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shree-ganesh-rem-1002863-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Shree Ganesh Remedies Ltd Falls to 52-Week Low Amidst Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-remedies-ltd-falls-to-52-week-low-amidst-continued-downtrend-3805765", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShreeGaneshReme_priceRelatedfactors_3805765.png", "date": "2026-01-27 10:40:18", "description": "Shree Ganesh Remedies Ltd touched a fresh 52-week low of Rs.381.1 today, marking a significant decline in its stock price amid persistent downward momentum. The pharmaceutical company’s shares opened sharply lower and underperformed the sector, reflecting ongoing pressures in its financial performance and market positioning." }, { "title": "Shree Ganesh Remedies Ltd Reports Sharp Decline in Quarterly Financial Performance Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-remedies-ltd-reports-sharp-decline-in-quarterly-financial-performance-amid-sector-challenges-3804862", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShreeGaneshReme_fintrenddot_3804862.png", "date": "2026-01-27 08:00:21", "description": "Shree Ganesh Remedies Ltd has reported a marked deterioration in its financial performance for the quarter ended December 2025, with key metrics such as revenue, profitability, and returns on capital contracting sharply. This downturn contrasts with the company’s historically robust growth trajectory and comes amid broader sectoral headwinds in Pharmaceuticals & Biotechnology." }, { "title": "Shree Ganesh Remedies Declines 2.83%: 3 Key Factors Behind the Weekly Slide", "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-remedies-declines-283-3-key-factors-behind-the-weekly-slide-3803291", "imagepath": "", "date": "2026-01-24 13:01:28", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>19 Jan:</strong> Stock opens at Rs.423.65, down 2.69%</p>\n <p><strong>20 Jan:</strong> Hits 52-week low of Rs.415 amid sharp decline</p>\n <p><strong>21 Jan:</strong> New 52-week low of Rs.399.95 recorded</p>\n <p><strong>22 Jan:</strong> Sharp rebound with 4.49% gain to Rs.421.15</p>\n <p><strong>23 Jan:</strong> Modest gain of 0.45% closes week at Rs.423.05</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.435.35</div></div>\n <div class=\"stat-item\"><div class=\"sta..." }, { "title": "Shree Ganesh Remedies Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/shree-ganesh-remedies-ltd-is-rated-strong-sell-3802960", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShreeGaneshReme_mojoScore_3802960.png", "date": "2026-01-24 10:10:39", "description": "Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 January 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Are Shree Ganesh Remedies Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-shree-ganesh-remedies-ltd-latest-results-good-or-bad-3802464", "imagepath": "", "date": "2026-01-23 19:17:36", "description": "Shree Ganesh Remedies Ltd's latest financial results present a mixed picture of performance. In the most recent quarter, the company reported net sales of ₹30.32 crores, reflecting a sequential growth of 22.90% from the previous quarter. However, this figure represents a decline of 6.22% compared to the same quarter last year, indicating challenges in maintaining revenue levels year-over-year.\n\nNet profit for the quarter stood at ₹4.96 crores, which shows a significant sequential recovery of 43.77% from the previous quarter's ₹3.45 crores. Nonetheless, this also marks a year-on-year decline of 22.62% from ₹6.41 crores in the corresponding quarter last year, highlighting ongoing profitability pressures.\n\nOperating margins, excluding other income, were reported at 31.76%, which is an improvement from the previous quarter's 29.59% but a decline from 34.95% in the same quarter last year. This compression in mar..." }, { "title": "Shree Ganesh Remedies Q2 FY26: Margin Pressure and Profitability Concerns Persist Despite Revenue Recovery", "link": "https://www.marketsmojo.com/news/result-analysis/shree-ganesh-remedies-q2-fy26-margin-pressure-and-profitability-concerns-persist-despite-revenue-recovery-3802389", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShreeGaneshReme_quaterlyResult_3802389.png", "date": "2026-01-23 18:01:44", "description": "Shree Ganesh Remedies Ltd., a pharmaceutical intermediates and fine chemicals manufacturer with a market capitalisation of ₹546.00 crores, reported net profit of ₹4.96 crores for Q2 FY26, marking a sequential improvement of 43.77% quarter-on-quarter but a concerning year-on-year decline of 22.62%. The Ankleshwar-based company's stock has been under severe pressure, trading at ₹424.00 and down 38.68% over the past year, significantly underperforming both the broader market and its pharmaceutical sector peers." }, { "title": "Shree Ganesh Remedies Ltd Falls to 52-Week Low of Rs.415", "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-remedies-ltd-falls-to-52-week-low-of-rs415-3796666", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShreeGaneshReme_priceRelatedfactors_3796666.png", "date": "2026-01-20 14:39:42", "description": "Shree Ganesh Remedies Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.415 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors." }, { "title": "Shree Ganesh Remedies Ltd Faces Bearish Momentum Amid Technical Downturn", "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-remedies-ltd-faces-bearish-momentum-amid-technical-downturn-3783958", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShreeGaneshReme_technicaldot_3783958.png", "date": "2026-01-07 08:24:29", "description": "Shree Ganesh Remedies Ltd has experienced a notable shift in price momentum, with technical indicators signalling a bearish trend. Despite a strong long-term performance, recent weekly and monthly charts reveal deteriorating momentum, prompting a downgrade in its Mojo Grade from Strong Sell to Sell as of 5 January 2026." }, { "title": "Shree Ganesh Remedies Ltd Shows Mixed Technical Signals Amid Price Momentum Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-remedies-ltd-shows-mixed-technical-signals-amid-price-momentum-shift-3782655", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShreeGaneshReme_technicaldot_3782655.png", "date": "2026-01-06 08:34:12", "description": "Shree Ganesh Remedies Ltd has exhibited a subtle shift in price momentum, reflected in a transition from a bearish to a mildly bearish technical trend. Despite a 1.76% gain on 6 Jan 2026, the stock’s technical indicators present a complex picture, with some oscillators signalling mild bullishness while others remain bearish, underscoring a cautious outlook for investors in the Pharmaceuticals & Biotechnology sector." } ], "total": 523, "sid": "1002863", "stock_news_url": "https://www.marketsmojo.com/news/shree-ganesh-remedies-1002863" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "24-Jan-2026", "details": "Newspaper publication for Financial Results", "source": "BSE" }, { "caption": "Financial Results For Quarter And Nine Months Ended December 31 2025", "datetime": "23-Jan-2026", "details": "Financial Results for quarter and nine months ended December 31 2025", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "23-Jan-2026", "details": "Press Release", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Shree Ganesh Remedies Ltd has declared <strong>5%</strong> dividend, ex-date: 07 Sep 23", "dt": "2023-09-07", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Shree Ganesh Remedies Ltd has announced <strong>1:5</strong> bonus issue, ex-date: 01 Nov 21", "dt": "2021-11-01", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Shree Ganesh Remedies Ltd has announced <strong>7:100</strong> rights issue, ex-date: 03 Feb 23", "dt": "2023-02-03", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

19 Jan: Stock opens at Rs.423.65, down 2.69%

20 Jan: Hits 52-week low of Rs.415 amid sharp decline

21 Jan: New 52-week low of Rs.399.95 recorded

22 Jan: Sharp rebound with 4.49% gain to Rs.421.15

23 Jan: Modest gain of 0.45% closes week at Rs.423.05

Week Open

Rs.435.35

Read full news article

Shree Ganesh Remedies Ltd is Rated Strong Sell

2026-01-24 10:10:39

Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Are Shree Ganesh Remedies Ltd latest results good or bad?

2026-01-23 19:17:36

Shree Ganesh Remedies Ltd's latest financial results present a mixed picture of performance. In the most recent quarter, the company reported net sales of ₹30.32 crores, reflecting a sequential growth of 22.90% from the previous quarter. However, this figure represents a decline of 6.22% compared to the same quarter last year, indicating challenges in maintaining revenue levels year-over-year. Net profit for the quarter stood at ₹4.96 crores, which shows a significant sequential recovery of 43.77% from the previous quarter's ₹3.45 crores. Nonetheless, this also marks a year-on-year decline of 22.62% from ₹6.41 crores in the corresponding quarter last year, highlighting ongoing profitability pressures. Operating margins, excluding other income, were reported at 31.76%, which is an improvement from the previous quarter's 29.59% but a decline from 34.95% in the same quarter last year. This compression in mar...

Read full news article

Shree Ganesh Remedies Q2 FY26: Margin Pressure and Profitability Concerns Persist Despite Revenue Recovery

2026-01-23 18:01:44

Shree Ganesh Remedies Ltd., a pharmaceutical intermediates and fine chemicals manufacturer with a market capitalisation of ₹546.00 crores, reported net profit of ₹4.96 crores for Q2 FY26, marking a sequential improvement of 43.77% quarter-on-quarter but a concerning year-on-year decline of 22.62%. The Ankleshwar-based company's stock has been under severe pressure, trading at ₹424.00 and down 38.68% over the past year, significantly underperforming both the broader market and its pharmaceutical sector peers.

Read full news article

Shree Ganesh Remedies Ltd Falls to 52-Week Low of Rs.415

2026-01-20 14:39:42

Shree Ganesh Remedies Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.415 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors.

Read full news article

Shree Ganesh Remedies Ltd Faces Bearish Momentum Amid Technical Downturn

2026-01-07 08:24:29

Shree Ganesh Remedies Ltd has experienced a notable shift in price momentum, with technical indicators signalling a bearish trend. Despite a strong long-term performance, recent weekly and monthly charts reveal deteriorating momentum, prompting a downgrade in its Mojo Grade from Strong Sell to Sell as of 5 January 2026.

Read full news article

Shree Ganesh Remedies Ltd Shows Mixed Technical Signals Amid Price Momentum Shift

2026-01-06 08:34:12

Shree Ganesh Remedies Ltd has exhibited a subtle shift in price momentum, reflected in a transition from a bearish to a mildly bearish technical trend. Despite a 1.76% gain on 6 Jan 2026, the stock’s technical indicators present a complex picture, with some oscillators signalling mild bullishness while others remain bearish, underscoring a cautious outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article